Drugs / 7x19 CAR-T
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06464861 | Jun 2024 → Jun 2026 overdue | mantle cell lymphoma, primary mediastinal large B-cell lymphoma | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 7x19 CAR-T | “after 1 week will be infused with 7x19 CAR-T at the dose of 2x10\^6/kg” NCT06464861 ↗ |
| Modality | Cell therapy | “7x19 CAR-T cells preparation and infusion” NCT06464861 ↗ |